Cart
sales@molnova.com
Home - Products - Angiogenesis - PDGFR - AG-1295

AG-1295

CAS No. 71897-07-9

AG-1295( NSC 380341 | Tyrphostin AG 1295 )

Catalog No. M15750 CAS No. 71897-07-9

A quinoxaline-type tyrphostin that acts as a potent and selective inhibitor of PDGFR kinase in vitro and in Swiss 3T3 cells with IC50 of 0.3-1 uM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 42 Get Quote
10MG 72 Get Quote
25MG 131 Get Quote
50MG 222 Get Quote
100MG 335 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote
1 mL x 10 mM in DMSO 49 In Stock
5MG 45 In Stock
10MG 76 In Stock
25MG 139 In Stock
50MG 230 In Stock
100MG 346 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    AG-1295
  • Note
    Research use only, not for human use.
  • Brief Description
    A quinoxaline-type tyrphostin that acts as a potent and selective inhibitor of PDGFR kinase in vitro and in Swiss 3T3 cells with IC50 of 0.3-1 uM.
  • Description
    A quinoxaline-type tyrphostin that acts as a potent and selective inhibitor of PDGFR kinase in vitro and in Swiss 3T3 cells with IC50 of 0.3-1 uM; inhibits PDGF-stimulated DNA synthesis with IC50 of 2.5 uM without affecting activity of EGFR; selectively attenuates smooth muscle cell growth in vitro and reduces neointimal formation after balloon angioplasty in swine.Blood Cancer Discontinued.
  • In Vitro
    Cell Viability Assay Cell Line:Rabbit conjunctival fibroblasts cells Concentration:1 μM, 10 μM, 100 μM Incubation Time:3 days Result:Inhibited rabbit conjunctival fibroblast cell growth stimulated by PDGF-AA or PDGF-BB.
  • In Vivo
    Animal Model:Sprague-Dawley rats (240-270 g)Dosage:12 mg/kg Administration:Intraperitoneal injection; daily; for 14 or 21 days Result:Attenuated interstitial fibrosis in rat kidney after unilateral obstruction.
  • Synonyms
    NSC 380341 | Tyrphostin AG 1295
  • Pathway
    Angiogenesis
  • Target
    PDGFR
  • Recptor
    PDGFR
  • Research Area
    Cancer
  • Indication
    Blood cancer

Chemical Information

  • CAS Number
    71897-07-9
  • Formula Weight
    234.3
  • Molecular Formula
    C16H14N2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (213.40 mM)
  • SMILES
    CC1=C(C)C=C2N=CC(C3=CC=CC=C3)=NC2=C1
  • Chemical Name
    6,7-dimethyl-2-phenyl-quinoxaline

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Kovalenko M, et al. Cancer Res. 1994 Dec 1;54(23):6106-14. 2. Banai S, et al. Circulation. 1998 May 19;97(19):1960-9. 3. Iwamoto H, et al. J Lab Clin Med. 2000 May;135(5):406-12. 4. Karck M, et al. Transplantation. 2002 Nov 15;74(9):1335-41.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Efinaconazole

    Efinaconazole(KP-103) is an Azole Antifungal currently under development as a topical treatment for onychomycosis.

  • JNJ-?10198409

    JNJ-?10198409 is a relatively selective and ATP competitive PDGF-RTK inhibitor (IC50=2 nM).

  • SU16f

    SU16f is a potent and selective PDGFRβ inhibitor (IC50s: 10 nM, 140 nM, 2.29 μM for PDGFRβ, PDGFR1, PDGFR2, respectively).

Sign In Join Free